Misonix, Inc. (NASDAQ: MSON) has their efforts focused on designing, developing, and manufacturing one of the broadest ranges of Therapeutic Ultrasonic Medical Devices. The company’s aim is to develop products that will improve patients’ quality of life by incorporating the highest level of quality and innovation into each and every product. Current application of their technology ranges from kidney stone pulverization and the aspiration of brain tumors to the latest technological breakthrough HIFU (High Intensity Focused Ultrasound) for various cancer treatments. For further information, visit the Company’s web site at www.misonix.com.
- 18 years ago
QualityStocks
Misonix, Inc. (NASDAQ: MSON)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Releases RoadSight UGV Demonstration Video
Safe Pro Group (NASDAQ: SPAI), has released a demonstration video highlighting its new RoadSight capability,…